This document discusses the history and science of drug testing in sports. It provides background on the types of performance enhancing drugs used by athletes and their effects. It then describes the anti-doping agencies and rules established to regulate drug use in sports. The document outlines the banned substances and methods according to their classifications. It details the sample collection and testing process, including the analytical methods used to detect drugs in urine and blood samples. Finally, it mentions some notable doping cases that have occurred in sports over time.
Doping refers to the use of banned performance enhancing substances or methods in sports. The World Anti-Doping Agency (WADA) was established in 1999 to promote doping-free sport and oversees the anti-doping process. Doping violates anti-doping rules and endangers health. Common banned substances include steroids to build muscle, EPO to increase oxygen delivery, and stimulants to mask fatigue. While doping aims to enhance performance, it can have serious side effects and India has seen many doping violations over the years.
This document provides a historical examination of performance enhancing substances and doping in sports. It defines various performance enhancing drugs such as anabolic steroids, blood doping, and human growth hormone. The document traces the history of doping back to ancient Greece and discusses how various international sports organizations have worked to ban doping over the 20th century. It also profiles three famous athletes - Ben Johnson, Marian Jones, and Lance Armstrong - who were caught doping and discusses some lesser known facts about doping scandals.
Doping in sports refers to the use of banned performance-enhancing substances or methods. It dates back to ancient Olympics where mushrooms and herbs were used. In the late 19th century, cyclists used cocaine and strychnine mixtures. The establishment of organizations like the IOC and WADA has led to increased regulation and bans on substances like anabolic steroids, EPO, and blood doping which threaten athlete health. While some athletes dope to gain competitive advantage, doping undermines fair competition and can have serious long-term health effects.
Drugs in sports can be used to enhance performance but also pose health risks. The World Anti-Doping Agency (WADA) prohibits performance-enhancing and recreational drugs through its code. It oversees an international system of drug testing in competitions and random tests. Banned substances include anabolic steroids, blood doping agents, stimulants, and diuretics. New concerns include gene doping and sample tampering. Athletes can apply for exemptions to use necessary medical treatments. In India, the National Anti-Doping Agency regulates testing according to WADA standards.
Drug abuse among athletes has been a problem for over 30 years. Various substances like amphetamines, cocaine, and strychnine have been used by athletes dating back to the late 19th century in an attempt to enhance performance. In recent decades, organizations like the IOC and WADA have worked to establish prohibited substance lists and testing protocols to detect and prevent doping among competitors. Some commonly abused classes of drugs include anabolic steroids, hormones, stimulants, and diuretics which athletes may use for both physiological and social reasons in their pursuit of victory.
This document discusses doping in competitive sports. It begins by defining doping as the use of banned performance-enhancing drugs. It then provides a brief history of doping, noting its origins in South Africa and the formation of anti-doping organizations. The document outlines reasons athletes use performance-enhancing drugs, including social and physiological factors. It categorizes and describes various classes of performance-enhancing drugs and their effects and health risks. These include anabolic agents, hormones, stimulants, and diuretics. The document also discusses anti-doping activities over time and organizations like WADA. Sample collection procedures and issues around false accusations are reviewed.
This document discusses the history and science of drug testing in sports. It provides background on the types of performance enhancing drugs used by athletes and their effects. It then describes the anti-doping agencies and rules established to regulate drug use in sports. The document outlines the banned substances and methods according to their classifications. It details the sample collection and testing process, including the analytical methods used to detect drugs in urine and blood samples. Finally, it mentions some notable doping cases that have occurred in sports over time.
Doping refers to the use of banned performance enhancing substances or methods in sports. The World Anti-Doping Agency (WADA) was established in 1999 to promote doping-free sport and oversees the anti-doping process. Doping violates anti-doping rules and endangers health. Common banned substances include steroids to build muscle, EPO to increase oxygen delivery, and stimulants to mask fatigue. While doping aims to enhance performance, it can have serious side effects and India has seen many doping violations over the years.
This document provides a historical examination of performance enhancing substances and doping in sports. It defines various performance enhancing drugs such as anabolic steroids, blood doping, and human growth hormone. The document traces the history of doping back to ancient Greece and discusses how various international sports organizations have worked to ban doping over the 20th century. It also profiles three famous athletes - Ben Johnson, Marian Jones, and Lance Armstrong - who were caught doping and discusses some lesser known facts about doping scandals.
Doping in sports refers to the use of banned performance-enhancing substances or methods. It dates back to ancient Olympics where mushrooms and herbs were used. In the late 19th century, cyclists used cocaine and strychnine mixtures. The establishment of organizations like the IOC and WADA has led to increased regulation and bans on substances like anabolic steroids, EPO, and blood doping which threaten athlete health. While some athletes dope to gain competitive advantage, doping undermines fair competition and can have serious long-term health effects.
Drugs in sports can be used to enhance performance but also pose health risks. The World Anti-Doping Agency (WADA) prohibits performance-enhancing and recreational drugs through its code. It oversees an international system of drug testing in competitions and random tests. Banned substances include anabolic steroids, blood doping agents, stimulants, and diuretics. New concerns include gene doping and sample tampering. Athletes can apply for exemptions to use necessary medical treatments. In India, the National Anti-Doping Agency regulates testing according to WADA standards.
Drug abuse among athletes has been a problem for over 30 years. Various substances like amphetamines, cocaine, and strychnine have been used by athletes dating back to the late 19th century in an attempt to enhance performance. In recent decades, organizations like the IOC and WADA have worked to establish prohibited substance lists and testing protocols to detect and prevent doping among competitors. Some commonly abused classes of drugs include anabolic steroids, hormones, stimulants, and diuretics which athletes may use for both physiological and social reasons in their pursuit of victory.
This document discusses doping in competitive sports. It begins by defining doping as the use of banned performance-enhancing drugs. It then provides a brief history of doping, noting its origins in South Africa and the formation of anti-doping organizations. The document outlines reasons athletes use performance-enhancing drugs, including social and physiological factors. It categorizes and describes various classes of performance-enhancing drugs and their effects and health risks. These include anabolic agents, hormones, stimulants, and diuretics. The document also discusses anti-doping activities over time and organizations like WADA. Sample collection procedures and issues around false accusations are reviewed.
The document discusses different categories of banned performance-enhancing drugs in sport including anabolic steroids, peptide hormones, painkillers, stimulants, and diuretics. It also notes some medications like asthma inhalers and beta blockers contain banned substances. The challenges around drug testing are discussed including better tests, different sanctions, and education. The process of random drug testing is outlined step-by-step from selecting samples to sealing and sending them anonymously to the lab.
The document discusses the history and definition of doping in sports. It traces doping back to ancient Greek times and provides key dates in the anti-doping movement, such as the establishment of the World Anti-Doping Agency in 1999. The health risks of doping with androgenic anabolic steroids are also summarized for both males and females.
Performance enhancing drugs (PEDs) have been used by athletes for centuries to improve performance. Early documented uses included swimmers in the 1860s taking drugs to speed up races. The first athlete to be disqualified for PED use was Hans-Gunnar Nilsson in 1968 after testing positive for cocaine and alcohol. Common PEDs used by athletes include anabolic steroids, human growth hormone, and creatine. However, using PEDs can have serious negative health effects and athletes caught using them often face bans and loss of titles and medals. Governing bodies continue developing better detection methods through urine and blood tests to curb PED use in sports.
This document discusses performance enhancing drugs used in sports. It begins by explaining that the competitive nature of sports can lead athletes to use prohibited drugs to gain an advantage. It then lists several commonly used classes of drugs like stimulants, anabolic steroids, human growth hormone, and diuretics. The document describes the intended physiological effects of these drugs and some potential health risks. It also discusses the role of the World Anti-Doping Agency in banning certain performance enhancing drugs and regulating drug testing in sports.
The document discusses doping in sports and the work of the World Anti-Doping Agency (WADA). It notes that doping threatens athletes' health and the integrity of sport. It defines doping and outlines WADA's prohibited list of banned substances and methods. The document also discusses nutritional supplements and notes the risks of contamination.
The document argues that drug testing should be required for all athletes at all levels to create a level playing field and protect athlete health. It notes that steroids, HGH, and amphetamines are commonly used drugs and discusses reasons for their use, including getting bigger, faster, stronger and recovering from injuries. It states that drug use should be tested for in high school, college, and professional sports. High school athletes may use drugs to get scholarships, while college athletes feel pressure to succeed and some professional sports have inconsistent testing. Mandatory random testing across all teams is recommended with severe punishments for positive tests to curb cheating.
The document discusses several high-profile cases of athletes being caught doping and facing suspensions, including:
- Maria Sharapova testing positive for meldonium in 2016 and receiving a two-year suspension.
- Lance Armstrong having his seven Tour de France titles revoked in 2012 after evidence of a doping scheme.
- Indian weightlifter Khumukcham Sanjita Chanu receiving a provisional suspension in 2018 after testing positive for testosterone.
It also provides information on the prevalence of doping in different sports in India, listing athletics, weightlifting, and powerlifting as having the most detected violations. Various reasons for athletes doping are discussed, such
In competitive sports, doping is the use of banned athletic performance-enhancing drugs by athletic competitors. The term doping is widely used by organizations that regulate sporting competitions. The use of drugs to enhance performance is considered unethical, and therefore prohibited, by most international sports organizations, including the International Olympic Committee. Furthermore, athletes (or athletic programs) taking explicit measures to evade detection exacerbate the ethical violation with overt deception and cheating.
The document discusses the history and current state of anti-doping efforts in sports. It notes that the first rules against doping were established in 1928 and that the World Anti-Doping Agency (WADA) was formed in 1999 to harmonize anti-doping policies worldwide. WADA maintains the prohibited substances list and oversees the international anti-doping code and standards. Key aspects of anti-doping addressed include testing protocols, therapeutic use exemptions, the prohibited substances list, and categories of banned performance-enhancing drugs.
This document discusses various types of performance enhancing drugs used in sports, including their purposes, effects, and side effects. It describes how anabolic steroids help build muscle faster, peptides like HGH and EPO increase oxygen in the blood, painkillers mask pain and allow quicker returns from injury, stimulants reduce fatigue and increase alertness, diuretics cause rapid weight loss, and beta-blockers maintain a slow heart rate and low blood pressure in tense situations. However, all such drugs carry potential health risks like organ damage, mood issues, and infertility.
This document discusses various topics related to doping in sports, including:
1. Concepts and classifications of doping according to various organizations.
2. Lists of prohibited substances and methods, along with examples and reasons for prohibition.
3. Responsibilities of athletes regarding anti-doping policies.
4. Potential side effects of commonly used prohibited substances like anabolic steroids, stimulants, and peptide hormones.
5. Types of ergogenic aids used to enhance sports performance, both legal and prohibited, including psychological, mechanical, pharmacological, physiological, and nutritional aids.
This document discusses drugs of abuse in sports. It defines doping and notes that the International Olympic Committee and World Anti-Doping Agency ban performance enhancing drugs. It then lists the different categories of prohibited substances and methods according to WADA, including anabolic agents, beta-2 agonists, diuretics, erythropoietin, and blood doping. It provides examples of specific prohibited drugs and their intended performance enhancing effects, as well as their health risks. The document aims to educate on the types of substances banned in competitive sports.
Brain fingerprinting is an investigative technique that measures brain wave responses to stimuli presented on a computer screen. It was developed by Dr. Lawrence Farwell to detect information stored in a person's brain related to a crime. The technique presents the subject with relevant and irrelevant words/pictures related to a crime while measuring electrical brain activity, particularly the P300 wave. If the brain response to crime-relevant information matches what only the perpetrator would know, it suggests the subject has knowledge of the crime. The technique has been successfully used in over 170 cases with 100% accuracy and could help identify criminals and exonerate the innocent. However, it only detects what information is stored, not how, and does not detect lies directly.
Forensic hypnosis is a technique which can help in investigation of criminal cases where leads have been exhausted. But it is of utmost importance that it should be conducted by an expert and person with strong knowledge of the area
The document discusses the history and definitions of doping in sports. It notes that doping refers to the use of prohibited substances or methods to gain an unfair advantage in sports. Key organizations that define doping include the World Anti-Doping Agency (WADA) and International Olympic Committee (IOC). The document also examines common doping methods like blood doping and gene doping as well as prohibited substances frequently used in different sports. It outlines athlete responsibilities and describes the process for blood and urine sample testing for doping.
This document discusses reinforcing doping control procedures for athletes. It outlines the doping control process, including types of tests (in-competition and out-of-competition), athlete notification procedures, the use of representatives, and sample collection requirements. Athletes must be cooperative and knowledgeable about their rights and responsibilities during testing. While athlete cooperation is improving, support personnel still need more awareness of doping control rules.
Blood doping is a procedure that increases the number of red blood cells in the body to enhance athletic performance and endurance. It works by allowing more oxygen to be carried to the muscles. Potential side effects include kidney damage, blood infections, heart problems, blood clots, and jaundice. Blood doping is mainly used in long distance endurance events like long distance running and cross country skiing to help athletes maintain performance for longer periods.
Doping in sports undermines the valuable lessons that sports can teach and is considered cheating. Doping refers to using performance-enhancing drugs and can have serious negative health effects. While some athletes dope to gain competitive advantages, it often leads to health issues like heart disease, mood disorders, and some cancers. The effects of doping can also differ between male and female athletes. To curb doping, many professional sports leagues have implemented drug testing programs.
This document discusses three common performance enhancing methods used in American sports: anabolic-androgenic steroids, human growth hormone, and blood doping. It provides details on the history, use, effects, and risks of each method. Detection techniques and legal/ethical issues related to performance enhancing drugs are also examined.
This document discusses various types and methods of doping in sports, including the use of therapeutic drugs, performance enhancing drugs, anabolic steroids, growth hormones, and blood doping. It describes the intended effects of these substances on athletic performance as well as potential health risks. Specifically, it provides details on the use of anabolic steroids and their androgenic and anabolic effects on muscle growth, but also side effects like liver and cardiovascular damage. The document also explains blood doping methods like autologous blood withdrawal and reinfusion or the use of erythropoietin to increase oxygen carrying capacity.
The document discusses different categories of banned performance-enhancing drugs in sport including anabolic steroids, peptide hormones, painkillers, stimulants, and diuretics. It also notes some medications like asthma inhalers and beta blockers contain banned substances. The challenges around drug testing are discussed including better tests, different sanctions, and education. The process of random drug testing is outlined step-by-step from selecting samples to sealing and sending them anonymously to the lab.
The document discusses the history and definition of doping in sports. It traces doping back to ancient Greek times and provides key dates in the anti-doping movement, such as the establishment of the World Anti-Doping Agency in 1999. The health risks of doping with androgenic anabolic steroids are also summarized for both males and females.
Performance enhancing drugs (PEDs) have been used by athletes for centuries to improve performance. Early documented uses included swimmers in the 1860s taking drugs to speed up races. The first athlete to be disqualified for PED use was Hans-Gunnar Nilsson in 1968 after testing positive for cocaine and alcohol. Common PEDs used by athletes include anabolic steroids, human growth hormone, and creatine. However, using PEDs can have serious negative health effects and athletes caught using them often face bans and loss of titles and medals. Governing bodies continue developing better detection methods through urine and blood tests to curb PED use in sports.
This document discusses performance enhancing drugs used in sports. It begins by explaining that the competitive nature of sports can lead athletes to use prohibited drugs to gain an advantage. It then lists several commonly used classes of drugs like stimulants, anabolic steroids, human growth hormone, and diuretics. The document describes the intended physiological effects of these drugs and some potential health risks. It also discusses the role of the World Anti-Doping Agency in banning certain performance enhancing drugs and regulating drug testing in sports.
The document discusses doping in sports and the work of the World Anti-Doping Agency (WADA). It notes that doping threatens athletes' health and the integrity of sport. It defines doping and outlines WADA's prohibited list of banned substances and methods. The document also discusses nutritional supplements and notes the risks of contamination.
The document argues that drug testing should be required for all athletes at all levels to create a level playing field and protect athlete health. It notes that steroids, HGH, and amphetamines are commonly used drugs and discusses reasons for their use, including getting bigger, faster, stronger and recovering from injuries. It states that drug use should be tested for in high school, college, and professional sports. High school athletes may use drugs to get scholarships, while college athletes feel pressure to succeed and some professional sports have inconsistent testing. Mandatory random testing across all teams is recommended with severe punishments for positive tests to curb cheating.
The document discusses several high-profile cases of athletes being caught doping and facing suspensions, including:
- Maria Sharapova testing positive for meldonium in 2016 and receiving a two-year suspension.
- Lance Armstrong having his seven Tour de France titles revoked in 2012 after evidence of a doping scheme.
- Indian weightlifter Khumukcham Sanjita Chanu receiving a provisional suspension in 2018 after testing positive for testosterone.
It also provides information on the prevalence of doping in different sports in India, listing athletics, weightlifting, and powerlifting as having the most detected violations. Various reasons for athletes doping are discussed, such
In competitive sports, doping is the use of banned athletic performance-enhancing drugs by athletic competitors. The term doping is widely used by organizations that regulate sporting competitions. The use of drugs to enhance performance is considered unethical, and therefore prohibited, by most international sports organizations, including the International Olympic Committee. Furthermore, athletes (or athletic programs) taking explicit measures to evade detection exacerbate the ethical violation with overt deception and cheating.
The document discusses the history and current state of anti-doping efforts in sports. It notes that the first rules against doping were established in 1928 and that the World Anti-Doping Agency (WADA) was formed in 1999 to harmonize anti-doping policies worldwide. WADA maintains the prohibited substances list and oversees the international anti-doping code and standards. Key aspects of anti-doping addressed include testing protocols, therapeutic use exemptions, the prohibited substances list, and categories of banned performance-enhancing drugs.
This document discusses various types of performance enhancing drugs used in sports, including their purposes, effects, and side effects. It describes how anabolic steroids help build muscle faster, peptides like HGH and EPO increase oxygen in the blood, painkillers mask pain and allow quicker returns from injury, stimulants reduce fatigue and increase alertness, diuretics cause rapid weight loss, and beta-blockers maintain a slow heart rate and low blood pressure in tense situations. However, all such drugs carry potential health risks like organ damage, mood issues, and infertility.
This document discusses various topics related to doping in sports, including:
1. Concepts and classifications of doping according to various organizations.
2. Lists of prohibited substances and methods, along with examples and reasons for prohibition.
3. Responsibilities of athletes regarding anti-doping policies.
4. Potential side effects of commonly used prohibited substances like anabolic steroids, stimulants, and peptide hormones.
5. Types of ergogenic aids used to enhance sports performance, both legal and prohibited, including psychological, mechanical, pharmacological, physiological, and nutritional aids.
This document discusses drugs of abuse in sports. It defines doping and notes that the International Olympic Committee and World Anti-Doping Agency ban performance enhancing drugs. It then lists the different categories of prohibited substances and methods according to WADA, including anabolic agents, beta-2 agonists, diuretics, erythropoietin, and blood doping. It provides examples of specific prohibited drugs and their intended performance enhancing effects, as well as their health risks. The document aims to educate on the types of substances banned in competitive sports.
Brain fingerprinting is an investigative technique that measures brain wave responses to stimuli presented on a computer screen. It was developed by Dr. Lawrence Farwell to detect information stored in a person's brain related to a crime. The technique presents the subject with relevant and irrelevant words/pictures related to a crime while measuring electrical brain activity, particularly the P300 wave. If the brain response to crime-relevant information matches what only the perpetrator would know, it suggests the subject has knowledge of the crime. The technique has been successfully used in over 170 cases with 100% accuracy and could help identify criminals and exonerate the innocent. However, it only detects what information is stored, not how, and does not detect lies directly.
Forensic hypnosis is a technique which can help in investigation of criminal cases where leads have been exhausted. But it is of utmost importance that it should be conducted by an expert and person with strong knowledge of the area
The document discusses the history and definitions of doping in sports. It notes that doping refers to the use of prohibited substances or methods to gain an unfair advantage in sports. Key organizations that define doping include the World Anti-Doping Agency (WADA) and International Olympic Committee (IOC). The document also examines common doping methods like blood doping and gene doping as well as prohibited substances frequently used in different sports. It outlines athlete responsibilities and describes the process for blood and urine sample testing for doping.
This document discusses reinforcing doping control procedures for athletes. It outlines the doping control process, including types of tests (in-competition and out-of-competition), athlete notification procedures, the use of representatives, and sample collection requirements. Athletes must be cooperative and knowledgeable about their rights and responsibilities during testing. While athlete cooperation is improving, support personnel still need more awareness of doping control rules.
Blood doping is a procedure that increases the number of red blood cells in the body to enhance athletic performance and endurance. It works by allowing more oxygen to be carried to the muscles. Potential side effects include kidney damage, blood infections, heart problems, blood clots, and jaundice. Blood doping is mainly used in long distance endurance events like long distance running and cross country skiing to help athletes maintain performance for longer periods.
Doping in sports undermines the valuable lessons that sports can teach and is considered cheating. Doping refers to using performance-enhancing drugs and can have serious negative health effects. While some athletes dope to gain competitive advantages, it often leads to health issues like heart disease, mood disorders, and some cancers. The effects of doping can also differ between male and female athletes. To curb doping, many professional sports leagues have implemented drug testing programs.
This document discusses three common performance enhancing methods used in American sports: anabolic-androgenic steroids, human growth hormone, and blood doping. It provides details on the history, use, effects, and risks of each method. Detection techniques and legal/ethical issues related to performance enhancing drugs are also examined.
This document discusses various types and methods of doping in sports, including the use of therapeutic drugs, performance enhancing drugs, anabolic steroids, growth hormones, and blood doping. It describes the intended effects of these substances on athletic performance as well as potential health risks. Specifically, it provides details on the use of anabolic steroids and their androgenic and anabolic effects on muscle growth, but also side effects like liver and cardiovascular damage. The document also explains blood doping methods like autologous blood withdrawal and reinfusion or the use of erythropoietin to increase oxygen carrying capacity.
This document discusses various topics related to doping in sports, including:
- Definitions of doping and performance-enhancing substances
- Types of doping methods like use of therapeutic drugs, blood doping, and stimulants
- Health risks of doping practices like steroids and blood doping
- Establishment of organizations like WADA to regulate anti-doping efforts
- Prevalence of doping among athletes and reasons some feel they need performance enhancers
Steroids can be abused for performance enhancement or to gain muscle mass. Various medical tests are used to detect steroid abuse, including urine toxicology testing, testosterone to epitestosterone ratio, and blood tests. Long-term steroid use and withdrawal can have negative health effects such as cardiovascular or liver damage. Emerging nuclear medicine imaging may help diagnose cardiovascular pathologies from steroid abuse.
Sports medicine aims to prevent and treat injuries in athletes. It also provides guidelines on drugs and doping to protect athletes' health and the integrity of competition. Doping refers to the use of banned substances or methods to enhance performance and gain an unfair advantage. The World Anti-Doping Agency (WADA) was established to harmonize anti-doping policies worldwide and prohibits various substances and methods that pose health risks or violate the spirit of sport, such as anabolic steroids, human growth hormone, blood doping, and gene doping. Athletes undergo in-competition and out-of-competition drug testing to detect the use of prohibited substances and ensure clean competition.
This document discusses performance enhancing drugs and doping in sports. It begins by defining performance enhancing drugs as substances that alter the body physically or psychologically to improve athletic performance. Examples given include steroids, hormones, stimulants and narcotics. The document then reviews the history of performance enhancing drug use in sports. It discusses the negative health effects of these drugs and why many see their use as unfair. Different types of performance enhancing substances are described like anabolic steroids, growth hormones, beta blockers and blood doping. The roles of drug testing and anti-doping agencies in regulating their use are also outlined.
Understanding Performance-Enhancing Drug UseDAVID WANG MD,.docxwillcoxjanay
Understanding Performance-Enhancing Drug Use
DAVID WANG MD, MS
ABSTRACT—Performance-enhancing drug use
is a prevalent problem in sports. It is a problem
that has captured the world's attention as the media
highlights story after story of athletes who have
transformed their bodies over a short period of time,
those who have simply defíed the aging process in
an attempt to prolong a career and those whose ca-
reers have been tarnished because of drug use. The
baseball investigations and the Mitchell Report*
of 2007 opened our eyes and gave us a glimpse of a
secretive underground world. This "world" is much
more intelligent and sophisticated than it is given
credit for. It is the goal of this article to increase the
awareness of the medical provider about the types of
steroids and other medications used, the influence
these substances have on the athletes, and how and
why they use them.
DAVID WANG,MD,MS,EliteSportsMedidne, Connecticut
Children's Medical Center.
D
RUG use is an area in sports medicine that is crucial
to recognize and is poorly studied, largely because
the use of performance-enhancing substances
are illegal and therefore rarely, if ever, reported. It is an
area difficult to gather scientific data about, but with the
severity of consequences from the use of these substances
it is imperative that the prudent practitioner is familiar
enough with the substances and practices that red flags
would be recognized and an open and honest discussion
with the patient on the wrong path could occur.
During the course of a 20-year practice of sports medi-
cine and I have encountered the use of these substances
by athletes of all sorts. I have spent time in a smaller
gym populated by serious bodybuilders and witnessed
practices most would not know existed. Through con-
versations with these bodybuilders, and I have learned of
the countless steroids that are "stacked" and the myriad
of other medications used to achieve their desired results
or to manage side effects. The medical community is well
aware of the existence of anabolic-androgenic steroids
and human growth hormone ( H G H ) and their use for
performance enhancement. However, most practitioners
are often not well versed on the specific types of steroids
and other medications that are used in combination with
these ergogenic aids. It is the "other" medications that
are responsible for much of the morbidity and mortal-
ity within this population. When these athletes die it
is often due to narcotic addiction and, to a much lesser
degree, anabolic steroids and growth hormone use. Al-
though the exact number of deaths is unknown, I have
seen and heard of several. In my experience and I have
witnessed or cared for several tragic deaths in training
and competition. The number of deaths witnessed from
drug use equals those observed from congenital heart
disease and head injury.
VOLUME 76, NO. 8 487
Initially our contact with an athlete can take place
during the preparticipation screeni ...
Anabolic steroids, amphetamines, androstenedione, and DHEA are some common ergogenic aids used by athletes to gain a competitive advantage. While these substances can enhance performance by increasing muscle mass, strength, and energy levels, they also carry significant health risks. Long-term anabolic steroid use has been shown to negatively impact the cardiovascular, reproductive, and liver systems. Amphetamines do not actually improve exercise performance and their use can cause nervousness, irritability, and difficulty sleeping. Androstenedione and DHEA supplementation provides no benefits to body composition in young athletes and may increase health risks by altering hormone levels. Due to their dubious benefits and clear health dangers, most sports organizations ban
Thank you for the feedback. I will incorporate your suggestions in any future presentations. The goal is to communicate information clearly and concisely while also properly citing sources.
The document discusses various performance-enhancing drugs and substances such as anabolic steroids, human growth hormone, erythropoietin, diuretics, creatine, and stimulants. It describes what each substance is, how athletes use it to gain a competitive advantage, and the associated health risks. While these drugs may appear to boost performance in the short term, the long term effects are unknown and they carry significant risks like organ damage, mental health issues, and even death. The document emphasizes that no matter the potential benefits claimed, using performance-enhancing drugs is a risky choice given the serious health consequences.
1) Male hypogonadism is caused by androgen deficiency and can affect multiple organ functions and quality of life. It has various forms that are caused by different factors and have implications for evaluation and treatment.
2) Diagnosis is based on clinical signs and symptoms of androgen deficiency along with low serum testosterone levels on two occasions. Treatment aims to restore testosterone levels to improve quality of life.
3) Testosterone replacement therapy options include oral, injectable, topical, and implant preparations. Risks include side effects and potential impacts on the prostate and cardiovascular and breast health that require monitoring.
Impact of anabolic steroids & other appearance & performance enhancing drugs ...MD Hammad Choudhary
Anabolic steroids are synthetic, or human-made variations of the male sex hormone testosterone. The proper term of these compounds is anabolic-androgenic steroids (AAS). These are the most popularly used class of Appearance & Performance enhancing drugs (APEDs) hence called steroidal APEDs.
RUNNING HEAD ANABOLIC-ANDROGENIC STEROID USE IN ATHLETES1.docxtoddr4
RUNNING HEAD: ANABOLIC-ANDROGENIC STEROID USE IN ATHLETES 1
Anabolic-Androgenic Steroid Use in Athletes and the
Associated Cardiovascular and Metabolic Effects
Michael W. McClellan
Des Moines University
Abstract
Anabolic-androgenic steroid use has become a popular drug for athletes and bodybuilders to use in order to improve their athletic performance despite health consequences associated with its use. The use of anabolic-androgenic steroids has been associated with adverse outcomes in prior studies, particularly in regards to cardiovascular and metabolic systems. In order to further evaluate the scientific data behind this proposition many studies reviewed were small, retrospective-prospective studies that systemically reviewed anabolic-androgenic steroid use and the cardiovascular effects associated such as hypertension, left ventricular hypertrophy, and myocardial infarction. Dyslipidemia was the only metabolic component reviewed due to the close interaction and indication it has for cardiovascular function. Past data collected on this topic has been very controversial and conflicting due to ethical limitations placed on anabolic-androgenic steroid use within the athletic community. Findings from this review will help athletes globally to understand the adverse effects associated with anabolic-androgenic steroid use. Healthcare providers will be able to identify potential steroid abuse, and educate these patients on the adverse outcomes associated, so they can help prevent future misuse and abuse.
The development of anabolic-androgenic steroids (AAS) were first seen in the early 1930’s when it was isolated from testosterone (Kanayama & Pope Jr., 2017). Soon after, there were many synthetic androgens developed such as testosterone propionate, stanozolol, and nandrolone, which are a few of the most common subtypes (Gheshlaghi, Piri-Ardakani, Masoumi, Behjati, & Paydar, 2015). As athletes and bodybuilders discovered the enhanced anabolic effects of each of these testosterone derivatives, it was not long until they became popular throughout the elite athletic population (Kanayama & Pope Jr., 2017). The improved performance seen throughout these individuals became the primary foundation for their use and eventually, abuse. The United States Food and Drug Administration has approved the use of anabolic-androgenic steroids as a form of hormone replacement therapy for men who have low testosterone production due to hypogonadism (Safety alerts for human medical products - testosterone and other anabolic androgenic steroids (AAS): FDA statement - risks associated with abuse and dependence.2016)). However, studies have shown that it is more commonplace for these synthetic drugs to be abused for cosmetic and personal performance rather than for any serious medical condition.
In a study conducted by Mitchell, it was found that over 30 major league baseball players reported the abuse of anabolic-androgenic st.
RUNNING HEAD ANABOLIC-ANDROGENIC STEROID USE IN ATHLETES1.docxhealdkathaleen
RUNNING HEAD: ANABOLIC-ANDROGENIC STEROID USE IN ATHLETES 1
Anabolic-Androgenic Steroid Use in Athletes and the
Associated Cardiovascular and Metabolic Effects
Michael W. McClellan
Des Moines University
Abstract
Anabolic-androgenic steroid use has become a popular drug for athletes and bodybuilders to use in order to improve their athletic performance despite health consequences associated with its use. The use of anabolic-androgenic steroids has been associated with adverse outcomes in prior studies, particularly in regards to cardiovascular and metabolic systems. In order to further evaluate the scientific data behind this proposition many studies reviewed were small, retrospective-prospective studies that systemically reviewed anabolic-androgenic steroid use and the cardiovascular effects associated such as hypertension, left ventricular hypertrophy, and myocardial infarction. Dyslipidemia was the only metabolic component reviewed due to the close interaction and indication it has for cardiovascular function. Past data collected on this topic has been very controversial and conflicting due to ethical limitations placed on anabolic-androgenic steroid use within the athletic community. Findings from this review will help athletes globally to understand the adverse effects associated with anabolic-androgenic steroid use. Healthcare providers will be able to identify potential steroid abuse, and educate these patients on the adverse outcomes associated, so they can help prevent future misuse and abuse.
Introduction
The development of anabolic-androgenic steroids (AAS) were first seen in the early 1930’s when it was isolated from testosterone (Kanayama & Pope Jr., 2017). Soon after, there were many synthetic androgens developed such as testosterone propionate, stanozolol, and nandrolone, which are a few of the most common subtypes (Gheshlaghi, Piri-Ardakani, Masoumi, Behjati, & Paydar, 2015). As athletes and bodybuilders discovered the enhanced anabolic effects of each of these testosterone derivatives, it was not long until they became popular throughout the elite athletic population (Kanayama & Pope Jr., 2017). The improved performance seen throughout these individuals became the primary foundation for their use and eventually, abuse. The United States Food and Drug Administration has approved the use of anabolic-androgenic steroids as a form of hormone replacement therapy for men who have low testosterone production due to hypogonadism (Safety alerts for human medical products - testosterone and other anabolic androgenic steroids (AAS): FDA statement - risks associated with abuse and dependence.2016)). However, studies have shown that it is more commonplace for these synthetic drugs to be abused for cosmetic and personal performance rather than for any serious medical condition.
In a study conducted by Mitchell, it was found that over 30 major league baseball players reported the abuse of anabolic-a ...
IAL Biology Unit 5 June 2015 - Scientific Article Sharmila Christy
This scientific article discusses drugs in sports and the issues surrounding their use and regulation. It covers the reasons athletes may take drugs, including as medication, to enhance performance, or recreationally. It then discusses drug testing protocols, banned substances, therapeutic use exemptions, and challenges around detecting new performance-enhancing drugs. The article also addresses ethical considerations around doctors aiding athletes and monitoring health impacts of banned drug use.
This scientific article discusses drugs in sports and the issues surrounding their use and regulation. It covers the reasons athletes may take drugs, including as medication, to enhance performance, or recreationally. It then discusses drug testing protocols, banned substances, therapeutic use exemptions, and some of the ethical issues around monitoring and penalizing drug use in competitive sports.
Male hypogonadism is caused by androgen deficiency which can negatively impact organ functions and quality of life. The goal of testosterone replacement therapy is to restore hormone levels to the normal range and alleviate symptoms. Common treatment options include injections, patches, gels, and implants which can restore sexual function, muscle strength, and bone density. Therapy requires monitoring for side effects like prostate issues or blood clots. Gonadotropins may also be used to stimulate testosterone production and spermatogenesis in hypogonadotropic hypogonadism.
Steroids in sports medicine by ankush mahajanAnkush Mahajan
Anabolic steroids are synthetic versions of testosterone that are often used to enhance strength and physique. While they can improve athletic performance, prolonged use has serious health risks. Steroid use shuts down the body's natural testosterone production and can negatively impact the reproductive, cardiovascular, and musculoskeletal systems. Side effects range from physical changes like acne to life-threatening conditions like heart attacks and liver cancer. Education is needed to increase awareness of both the benefits and serious risks of anabolic steroid use among athletes and bodybuilders.
1) The document discusses endocrine disorders and diabetic emergencies. It provides objectives, definitions of key terms, and descriptions of the pathophysiology of conditions like diabetes mellitus, hypoglycemia, and hyperglycemia.
2) Details are given on assessing patients for endocrine-related complaints like altered mental status and weaknesses. Common causes like acidosis, infection, and insulin problems are reviewed.
3) The differences between type 1 and type 2 diabetes are outlined, including causes, risks, complications, and management of hypoglycemia and hyperglycemic emergencies for each.
Similar to COMMON DOPING CHEMICALS AND ITS PHARMACOLOGY (20)
3rd DC- unit 5.pptx.........................Madona Mathew
This document discusses alcohol abuse and its effects, as well as treatment options. Alcohol abuse can negatively impact physical and mental health. While alcohol addiction is treatable, it often requires an integrated approach including therapy, support groups, and medication management.
The document discusses the multidisciplinary nature of environmental studies. It states that environmental studies utilizes information from different fields of science like physical science, life science, technology, and management to address various environmental problems. It also describes the different components, segments and resources that make up the environment. Some of the key issues covered include deforestation, water and soil degradation, and the importance of conserving natural resources and ecosystems.
This document provides an overview of wildlife forensics. It defines wildlife forensics as the application of natural and cultural sciences like biology, chemistry, and anthropology in legal cases related to wildlife protection and conservation. The document outlines different types of wildlife crimes and lists some national acts and schedules. It also discusses protected and endangered species, as well as identifying physical evidence in wildlife crime investigations.
nanotechnology in forensic science......Madona Mathew
Nanomaterial-based biosensors have revolutionized forensic science by offering unprecedented capabilities for evidence analysis. These biosensors integrate nanotechnology with biosensor technology to achieve greater precision and efficiency in detecting crucial biomarkers, trace elements, and chemical compounds relevant to criminal investigations. They are employed in the sensitive detection of biological fluids, drugs, toxins, and explosives, aiding in reconstructing events and identifying illicit activities. Moreover, nanomaterial-based biosensors show promise in forensic pathology for determining causes of death and postmortem intervals by analyzing tissue samples. As the technology continues to advance, biosensors are expected to further expand their applications and transform traditional forensic techniques through improved sensitivity, selectivity, portability, and integration with data
This document discusses the field of forensic entomology and its applications in criminal investigations. It explains that forensic entomologists can estimate the post-mortem interval (PMI) by analyzing the insects and arthropods present on a corpse based on their life cycles. Different types of insects are attracted to corpses at various stages of decomposition. Factors like temperature, climate and toxin presence can affect decomposition and insect colonization. The document outlines several high-profile criminal cases where forensic entomological evidence provided crucial insights like PMI estimates, implicating suspects, and reconstructing crime timelines. It also discusses career paths for forensic entomologists.
The document describes a polarized light microscope. It explains that a polarized light microscope uses a polarizer to convert unpolarized light into plane-polarized light before it hits the sample. When this polarized light hits a doubly refracting sample, it generates two wave components that are analyzed to produce a high-contrast image. Key parts of the microscope include the polarizer, analyzer, specialized rotating stage, strain-free objectives, and optional compensators. Polarized light microscopy is useful for forensic applications like analyzing hair samples and identifying trace evidence like fibers, crystals, and soil.
GEQD stands for Government Examiner of Questioned Documents and it refers to a government position with the basic task of providing forensic document analysis and services.
Alberto Fujimori, the former president of Peru from 1990 to 2000, was accused and convicted of embezzling hundreds of millions of government funds along with his director of national intelligence Vladimiro Montesinos. Fujimori fled Peru in 2000 amid corruption scandals and was later extradited from Chile to face criminal charges in Peru, where he was convicted of human rights violations and sentenced to 25 years in prison, as well as additional sentences for embezzlement and bribery totaling over 30 years. To date, around $250 million stolen by Montesinos and Fujimori has been repatriated, though $380 million is still allegedly missing.
This document discusses forensic science and provides information about entering the field. It outlines educational requirements like obtaining a bachelor's degree in a natural science and a master's degree in forensic science. It lists top forensic science colleges in India and careers in the field like crime scene investigation, forensics odontology, and digital forensics. Government job options are also presented, including working for the Directorate of Forensic Science Services or Central Bureau of Investigation.
Cocoa is the plant from which chocolate is made.
Bitter chocolate is produced by pressing roasted cocoa kernels (seeds) between hot rollers.
Cocoa powder is produced by squeezing the fat (cocoa butter) from bitter chocolate and powdering the remaining material.
Sweet chocolate is produced by adding sugar and vanilla to bitter chocolate. White chocolate contains sugar, cocoa butter, and milk solids.
Forensics plays a vital role in crime investigations by analyzing various types of evidence. Trace evidence like fibers, soil and hair can provide links between suspects and victims. Impression evidence like fingerprints and toolmarks are analyzed and compared. Fire investigations examine fire scenes to determine origins and causes. Fingerprints, DNA, documents, digital data, toxicology reports, ballistics, anthropology, pathology, odontology and psychology are all important forensic specialties that aid investigations and legal proceedings by analyzing physical and biological evidence scientifically.
The document summarizes the interaction of insects with vertebrate corpses at different stages of decomposition. It discusses how different insects are attracted to corpses depending on the stage of decomposition, from blowflies and flesh flies in the initial fresh stage to mites and collembola in the dry decay stage. The succession of insect species and their larvae on corpses can be used in forensic science to estimate the post-mortem interval and provide other details about the crime scene.
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
The debris of the ‘last major merger’ is dynamically youngSérgio Sacani
The Milky Way’s (MW) inner stellar halo contains an [Fe/H]-rich component with highly eccentric orbits, often referred to as the
‘last major merger.’ Hypotheses for the origin of this component include Gaia-Sausage/Enceladus (GSE), where the progenitor
collided with the MW proto-disc 8–11 Gyr ago, and the Virgo Radial Merger (VRM), where the progenitor collided with the
MW disc within the last 3 Gyr. These two scenarios make different predictions about observable structure in local phase space,
because the morphology of debris depends on how long it has had to phase mix. The recently identified phase-space folds in Gaia
DR3 have positive caustic velocities, making them fundamentally different than the phase-mixed chevrons found in simulations
at late times. Roughly 20 per cent of the stars in the prograde local stellar halo are associated with the observed caustics. Based
on a simple phase-mixing model, the observed number of caustics are consistent with a merger that occurred 1–2 Gyr ago.
We also compare the observed phase-space distribution to FIRE-2 Latte simulations of GSE-like mergers, using a quantitative
measurement of phase mixing (2D causticality). The observed local phase-space distribution best matches the simulated data
1–2 Gyr after collision, and certainly not later than 3 Gyr. This is further evidence that the progenitor of the ‘last major merger’
did not collide with the MW proto-disc at early times, as is thought for the GSE, but instead collided with the MW disc within
the last few Gyr, consistent with the body of work surrounding the VRM.
ESPP presentation to EU Waste Water Network, 4th June 2024 “EU policies driving nutrient removal and recycling
and the revised UWWTD (Urban Waste Water Treatment Directive)”
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
The technology uses reclaimed CO₂ as the dyeing medium in a closed loop process. When pressurized, CO₂ becomes supercritical (SC-CO₂). In this state CO₂ has a very high solvent power, allowing the dye to dissolve easily.
1. COMMON DOPING CHEMICALS AND ITS
PHARMACOLOGY
BY,
MADONA MATHEW, MANASA GUNDU & LASSIN RAJ. B. R
SCHOOL OF FORENSIC SCIENCE & RISK MANAGEMENT
RAKSHA SHAKTI UNIVERSITY, GUJARAT
2. INTRODUCTION
Substances and doping methods are banned when they
meet at least two of the three following criteria:
Enhance performance
Pose a threat to athlete health
Violate the spirit of sport.
3. SUBSTANCES AND METHODS USED FOR DOPING IN
SPORT
ANABOLIC STEROIDS
• THEY ARE ALSO REFERRED TO AS ERGOGENIC OR
PERFORMANCE ENHANCING DRUGS.
• THEY ARE SYNTHETIC DERIVATIVES OF TESTOSTERONE.
• THEY AFFECT MUSCLE GROWTH, RAISING LEVELS IN THE
BLOOD COULD HELP ATHLETES TO INCREASE MUSCLE SIZE
AND STRENGTH, REDUCE BODY FAT AND RECOVERY TIME
AFTER INJURY.
4. Anabolic drugs banned by NCAA: Boldenone, Testosterone,
Dromostanolone,Dihydrotestosterone,Methenolone,Norethandrol
one,Oxymetholone,Clostebol.
Oral Steroids: Oral, fat-soluble steroids can be detected in the
body for several weeks or months after a person stops taking
them.
Injectable Steroids: Injectable anabolic are injected into muscle
tissue. They are slowly released from the muscles into the rest of
the body, and may be detectable for months after last use. The
body tolerates the injectable steroids more effectively than the
oral steroids. Long-term steroid abusers use them for this reason.
5. Medical use of Anabolic steroids
They are classified as Schedule III drugs in accordance with the
Controlled Substances Act .
These are available legally as prescribed medications for treating
anemia, osteoporosis, growth stimulation, gonadal dysfunction,
and gynecological disorders.
Medically, androgens and anabolic steroids are used to treat:
delayed puberty in adolescent boys, hypogonadism and
impotence in men, breast cancer in women, anemia, osteoporosis,
weight loss disease in HIV, endometriosis, other conditions with
hormonal imbalance.
6. Effects
They can cause:
Cancer of the liver, prostate, kidney
Reduction in HDL the "good" cholesterol, high blood pressure, enlarged
prostate, liver damage, aggressive behavior, post-use depression.
Aching joints, injury to tendons, ligaments, and muscles, blood coagulation
disorders, HIV disease from sharing needles, acne, swelling of feet or ankles,
nosebleeds, reduced libido.
Increased sex drive, increased fatty deposits, heart arrhythmia's, stunted
growth in immature individuals, breast growth in males, reduced sperm
count, shrinking of the testicles.
Baldness, body hair growth in female, masculinization, clitoral enlargement
and breast reduction in females.
7. HUMAN GROWTH HORMONE (HGH)
Hormone that is naturally produced by the body.
It is synthesized and secreted by cells in the anterior pituitary gland located at
the base of the brain.
In serum, hGH exists as a complex molecular forms (isoforms), including the
major 22-kDa form and minor isoforms such as the 20-kDa form.
hGH also exists as aggregates of these isoforms (dimers and oligomers, forming
both homo- and heterodimers). The 22-kDa hGH has a short half-life of 10-20
minutes.
Effect of Hgh on athletes performance: include the reduction of body fat
(lipolysis), the increase in muscle mass and strength (anabolic effect).
Increases in total body protein turnover and muscle synthesis. hGH also appears
to be used synergistically with other performance-enhancing drugs, thus having
an effect, albeit indirect, on muscle anabolism and athletic performance.
8. SIDE AFFECTS
• DIABETES IN PRONE INDIVIDUALS, WORSENING OF
CARDIOVASCULAR, DISEASES, MUSCLE, JOINT AND BONE PAIN,
HYPERTENSION AND CARDIAC DEFICIENCY, ABNORMAL GROWTH OF
ORGANS, ACCELERATED OSTEOARTHRITIS.
• EXCESSIVE USE OF HGH MAY ALSO LEAD TO METABOLIC
DYSFUNCTION, INCLUDING GLUCOSE INTOLERANCE AND OTHER SIDE
EFFECTS ASSOCIATED WITH EXCESS LEVELS OF IGF-1.
9. TEST
Athletes use hGH as a doping agent for extended periods of time in order
to benefit from its purported performance-enhancing effects In addition,
doping athletes suspect that they may be tested for hGH during
competition periods.
The blood matrix is the most suitable matrix for the detection of hGH.
hGH in urine is found in extremely small quantities (less than 1% than
that found in blood). Freezing blood serum is a scientifically acceptable
procedure that allows for the preservation of substances in samples for
future testing and detection.
Isoform test and Biomarkers test.
10. INSULIN LIKE GROWTH FACTOR 1
A protein involved in the mediation of the growth hormone. Administration
of IGF-1 could cause heart disease and cancer.
Detection
The world anti doping agency is the main regulatory organization looking
into the issue of the detection of gene doping.
Directly detecting the use of gene therapy usually requires the discovery of
recombinant proteins or gene insertion vectors.
While most indirect methods involve examining the athlete in an attempt to
detect bodily changes or structural differences between endogenous and
structural differences between endogenous recombinant proteins.
11. BLOOD DOPING
• BLOOD DOPING IS AN ILLICIT METHOD OF IMPROVING ATHLETIC
PERFORMANCE BY ARTIFICIALLY BOOSTING THE BLOOD’S ABILITY TO
BRING MORE OXYGEN TO MUSCLES.
• IT INCREASES THE AMOUNT OF HEMOGLOBIN IN THE BLOOD STREAM.
IT ALLOWS HIGHER AMOUNT OF OXYGEN AND FUEL TO ATHLETES
MUSCLES THAT CAN GIVE STAMINA AND IMPROVE PERFORMANCE.
12. TYPES OF BLOOD DOPING
Blood transfusions: In normal practice patients may undergo
blood transfusions to replace blood lost due to injury. it also boost
athletes performance. it includes two types;
Autologous transfusion: this involves transfusions of athletes
own blood. there are no direct tests to detect. one method
involves comparing an athletes blood profile at testing time to
blood samples collected at previous times. Difference indicates
blood doping.
Homologous transfusion: this involves athletes use someone's
blood.it can detected by testing blood samples.
13. RISKS OF BLOOD DOPING
It increases the risk of blood clotting , heart attack, and
stroke.
Tainted blood can spread infectious diseases such as ; HIV,
hepatitis B, hepatitis C.
Repeated blood transfusion can cause a dangerous build up
of iron in the body.
Improperly stored blood and improperly administrated
transfusion can cause acute lung injury.
14. ERYTHROPROTEIN
• A GLYCO PROTEIN THAT ACTS AS A HORMONE, CONTROLLING RED BLOOD
CELLS PRODUCTION.
• ATHLETES HAVE INJECTED THE EPO PROTEIN AS A PERFORMANCE
ENHANCING SUBSTANCE FOR MANY YEARS.
• WHEN THE ADDITIONAL EPO PRODUCTION OF RBC IN CIRCULATION, THIS
INCREASES THE AMOUNT OF OXYGEN AVAILABLE TO MUSCLE, ENHANCING
THE ATHLETES ENDURANCE.
• EPO IS A NATURALLY PRODUCED HORMONE. IT IS RELEASED FROM THE
KIDNEYS AND ACTS ON BONE MARROW TO INCREASE THE RED BLOOD
CELLS.
• BY INJECTING EPO ,ATHLETES AIM TO INCREASE RBC AND AEROBIC
CAPACITY.
15. EPO is a hormone produced by the kidney. it regulates the body's
production RBC.
Blood and urine tests can detect the presence of synthetic EPO,
but EPO remains in the body for very short time, while its effect
last much longer.
16. SYNTHETIC OXYGEN CARRIERS
Synthetic oxygen carriers, such as hemoglobin-based oxygen
carriers (HBOCs) or perfluorocarbons (PFCs), are purified proteins
or chemicals that have the ability to carry oxygen.
They are useful for emergency therapeutic purposes when human
blood is not available, the risk of blood infection is high or when
there is not enough time to properly cross-match donated blood
with a recipient.
The misuse of synthetic oxygen carriers for doping purposes carries
the risk of cardiovascular disease in addition to serious side effects
such as strokes, heart attacks and embolisms.
17. These are the chemicals that have ability to carry oxygen.
It is used when patient needs a blood transfusion human blood is not available ,
there is a high risk of blood infection.
Athletes use them to increase oxygen the blood.
18. Athletes use synthetic oxygen carriers for the same performance-enhancing
effects of other types of blood doping -- increased oxygen in the blood that
helps fuel muscles.
Synthetic oxygen carriers are, just as the name implies, chemicals that have
the ability to carry oxygen within the body. Two examples are:
HBOCs (hemoglobin-based oxygen carriers)
PFCs (perfluorocarbons)
19. GENE DOPING
Gene doping is the hypothetical non-therapeutic use of gene therapy by
athletes in order to improve their performance.
As of April 2015, there is no evidence that gene doping has been used
for athletic performance-enhancement in any sporting events.
Gene doping would involve the use of gene transfer to increase or
decrease gene expression and protein biosynthesis of a specific human
protein.
This could be done by directly injecting the gene carrier into the person,
or by taking cells from the person, transfecting the cells, and
administering the cells back to the person.
Genetic enhancement includes manipulation of genes or gene
transfer by healthy athletes for the purpose of physically improving
their performance.
20. AGENTS
There are numerous genes of interest as agents for gene doping.
They include EPO, insulin-like growth factor 1, human growth
hormone, myostatin, vascular endothelial growth factor, fibroblast growth
factor, endorphin, enkephalin and alpha-actinin-3.
The risks of gene doping would be similar to those of gene therapy: immune
reaction to the native protein leading to the equivalent of a genetic disease,
massive inflammatory response, cancer, and death, and in all cases, these
risks would be undertaken for short-term gain as opposed to treating a
serious disease.
21. Myostatin
Myostatin is a protein responsible for inhibiting muscle differentiation and growth.
Removing the myostatin gene or otherwise limiting its expression leads to an
increase in muscle size and power.
Humans born with defective genes can also serve as "knockout models"; a German
boy with a mutation in both copies of the myostatin gene was born with well-
developed muscles.
Insulin
Insulin is a hormone secreted by the pancreas and composed of two peptide chains.
Insulin increases the production of glycogen (i.e. the formation of the sugar stored in
the body), promotes glucose and amino acids intake into cells, accelerates protein
synthesis, and decreases the protein breakdown.
Thus, insulin is anabolic, meaning that it is a tissue-growing hormone.
22. DIURETICS
Diuretics are drugs that increase the rate of urine flow and sodium excretion
to adjust the volume and composition of body fluids.
There are several major categories of this drug class and the compounds vary
greatly in structure, physicochemical properties, effects on urinary
composition and renal hemodynamics, and site and mechanism of action.
Diuretics are often abused by athletes to excrete water for rapid weight loss
and to mask the presence of other banned substances.
The World Anti-Doping Agency's (WADA) list of prohibited substances; the
use of diuretics is banned both in competition and out of competition and
diuretics are routinely screened for by anti-doping laboratories.
23. USES
Diuretics are therapeutic agents that are used to increase the rate of urine flow
and sodium excretion in order to adjust the volume and composition of body
fluids or to eliminate excess of fluids from tissues.
They are used in clinical therapy for the treatment of various diseases and
syndromes, including hypertension, heart failure, liver cirrhosis, renal failure,
kidney and lung diseases, as well as a more general reduction of the adverse
effects of salts and/or water retention.
Diuretics were first banned in sport (both in competition and out of
competition) in 1988.
24. BETA BLOCKERS
Beta blockers, also known as beta-adrenergic blocking agents and are medications
that reduces blood pressure.
Beta blockers work by blocking the effects of the hormone epinephrine, also known
as adrenaline.
Beta blockers causes heart to beat more slowly and with less force, which lowers
blood pressure and helps open up your veins and arteries to improve blood flow.
Some of the Beta Blockers are: Acebutolol, Esmolol, Propranolol, Alprenol, Atenolol,
Betaxolol, Bisoprolol, Bunolol, Carteolol, Carvedilol, Celiprolol, Labetalol,
Metipranolol, Metoprolol, Nadolol, Oxprenolol, Pindolol, Sotalol, Timolol
Examples of beta blockers taken by mouth include: Acebutolol (Sectral), Atenolol
(Tenormin), Bisoprolol (Zebeta), Metoprolol (Lopressor, Toprol XL), Nadolol
(Corgard), Nebivolol (Bystolic)
25. STIMULANTS
Stimulants are drugs that directly affect the central nervous system.
They work to speed up parts of the brain and body, increasing the heart rate,
blood pressure, metabolism and body temperature of the user.
They are used by athletes to reduce tiredness and fatigue, and to increase
alertness, competitiveness and aggressiveness.
Stimulants are drugs that usually act on the central nervous system to
modulate mental function and behavior, increasing an individual's sense of
excitement and decreasing the sensation of fatigue.
Athletes may have stimulants in their body for one of three main reasons:
Inadvertent (or alleged inadvertent) consumption in a propriety medicine,
Deliberate consumption for misuse as a recreational drug, Deliberate
consumption to enhance performance.
Stimulants may be taken to increase alertness or convey some psychological
motivational or attitude advantage from central actions.
26.
27. NUTRITIONAL SUPPLEMENTS
A large number of recreational and elite athletes use nutritional supplements in
hopes of improving performance.
Due to the lack of regulation of the dietary supplement industry, an abundance of
supplement products of dubious value, content, and quality are now available
around the world.
For athletes, lack of knowledge or misinformation has been established despite
numerous sources of information being available, and the reasons for, and
implications of, unsupervised and unrestricted supplement use require further
attention.
In addition to the necessity of an appropriate regulation of dietary supplements,
nutritional education and scientifically sound guidance for athletes is required.
Intervention and prevention efforts should be particularly targeted to adolescents
For more than a decade, it has been known that nutritional supplements can be
“contaminated” with doping substances, which means that the contents of the
supplements are not identical to the list of ingredients on the label.
28. CONCLUSION
After critically looking at all aspects of performance-enhancing drug use, we
have concluded, as a team, that doping is negatively affecting sports.
Performance-enhancing drugs is a bad thing for several reasons.
They have terrible side effects on athletes and destroy their bodies in the long
run.
At present, the problem of the use of doping by athletes is acute for
professional sports.
The solution of this task immediately entails chain of related questions: how to
improve the system of doping control, what drugs to prohibit to use, what
measures to show to athletes who violated the rules.
29. REFERENCES
Eichner, E. R. (1992). Sports anemia, iron supplements, and blood doping. Medicine and
science in sports and exercise, 24(9 Suppl), S315-8.
Unal, M., & Unal, D. O. (2004). Gene doping in sports. Sports Medicine, 34(6), 357-362.
Thevis, M., Sigmund, G., Geyer, H., & Schänzer, W. (2010). Stimulants and doping in
sport. Endocrinology and Metabolism Clinics, 39(1), 89-105.
Cadwallader, A. B., De La Torre, X., Tieri, A., & Botrè, F. (2010). The abuse of diuretics as
performance‐enhancing drugs and masking agents in sport doping: pharmacology,
toxicology and analysis. British journal of pharmacology, 161(1), 1-16.
Schumacher, Y. O., & Ashenden, M. (2004). Doping with artificial oxygen carriers. Sports
Medicine, 34(3), 141-150.
Schneider, A. J., & Friedmann, T. (2006). The problem of doping in sports. Advances in
genetics, 51, 1-9.